Advertisement

Topics

General Catalyst Partners Company Profile

18:02 EDT 23rd June 2018 | BioPortfolio

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead innovation and transform industries. Founded in 2000, General Catalyst Partners leverages its principals' extensive operational, business development and technological expertise to provide portfolio companies with a catalyst for success through business-building and partnership development assistance. General Catalyst has offices in Cambridge, MA and Palo Alto, CA. For more information, visit: www.generalcatalyst.com.


News Articles [889 Associated News Articles listed on BioPortfolio]

Ken Chenault to Join General Catalyst

NEW YORK, Jan. 29, 2018/PRNewswire/ -- General Catalyst, a venture capital firm that makes early-stage and transformational investments, today announced that Ken Chenault Read more...

Livongo, Led By Ex-Allscripts CEO, Gets $105M for Health Tech Tools

Livongo Health, a startup that develops connected devices and software for patients with diabetes and other chronic conditions, said earlier this week it had raised $105 million from investors to supp...

A simple catalyst helps to assemble complex molecular frameworks of antifungal agents

(AKSON Russian Science Communication Association) A team of Russian chemists led by Professor Dmitry Perekalin from Nesmeyanov Institute of Organoelement Compounds have recently developed a new rhodiu...

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q1 2018 Results - Earnings Call Transcript

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q4 2017 Results - Earnings Call Transcript

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromusc...

Drugs and Medications [22 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [1249 Associated PubMed Articles listed on BioPortfolio]

Concurrent validity of the Partners in Health scale against general self-rated health in chronic conditions: A short report.

The Partners in Health scale is a structurally valid measure of chronic condition self-management behaviours. This report describes a study that further evaluated construct validity of Partners in Hea...

Silica-Supported Lanthanocene(II) - (SiO)LnCp* (Ln = Yb, Sm): Ultra High Molecular Weight Polyethylene without co-Catalyst.

Designing highly active supported ethylene polymerization catalysts that do not require a co-catalyst to generate electrophilic metal alkyl species is still a challenge despite its industrial relevanc...

A General Palladium-Phosphine Complex for Exploring Aryl Tosylates in N-arylation of Amines: Scope and Limitation.

The scope and limitation of mono-selective N-arylation of various amines using aryl or heteroaryl tosylates are presented. Air-stable and easily accessible Pd(OAc)2/CM-phos catalyst system was found c...

Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial.

This study evaluated the process and outcome of a psychosocial intervention for men with prostate cancer and their partners. As more men survive prostate cancer, they and their partners need help and ...

Industrial wastewater advanced treatment via catalytic ozonation with an Fe-based catalyst.

An Fe-based catalyst was used as a heterogeneous catalyst for the ozonation of industrial wastewater, and key operational parameters (pH and catalyst dosage) were studied. The results indicated that t...

Clinical Trials [2032 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

A Case Control Study of Women With Multiple Sexual Partners

Both population based surveys and more focused research studies indicate that increased numbers of sexual partners and partner concurrency contribute to increased risk for acquisition of s...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [1696 Associated Companies listed on BioPortfolio]

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

SynapDx Corporation

SynapDx is a private company providing laboratory diagnostic services to physicians who suspect children of developmental disorders, with the initial goal of enabling earli...

Catalyst Communications

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. ...

More Information about "General Catalyst Partners" on BioPortfolio

We have published hundreds of General Catalyst Partners news stories on BioPortfolio along with dozens of General Catalyst Partners Clinical Trials and PubMed Articles about General Catalyst Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of General Catalyst Partners Companies in our database. You can also find out about relevant General Catalyst Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record